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Abstract
Objectives-To assess outside a clinical trial the psychological outcome of different treatment policies in women with early breast cancer who underwent either mastectomy or breast conservation surgery depending on the surgeon's opinion or the patient's choice. To Interventions-Surgery and radiotherapy or adjuvant chemotherapy, or both, depending on the individual surgeon's stated preferences for managing early breast cancer.
Main outcome measures-Anxiety and depression as assessed by standard methods two weeks, three months, and 12 months after surgery.
Results-Of the 269 women, 31 were treated by surgeons who favoured mastectomy, 120 by surgeons who favoured breast conservation, and 118 by surgeons who offered a choice of treatment. Sixty two of the women treated by surgeons who offered a choice were eligible to choose their surgery, and 43 of these chose breast conserving surgery. The incidences of anxiety, depression, and sexual dysfunction were high in all treatment groups. There were no significant differences in the incidences of anxiety and depression between women who underwent mastectomy and those who underwent lumpectomy. A 
Introduction
There have been numerous reports in medical journals' and the lay press23 of the psychological trauma produced by the diagnosis and treatment of breast cancer. It was hoped that breast conserving techniques would reduce psychiatric morbidity and sexual dysfunction, but these predictions have not been confirmed. At least 13 studies have compared the psychological impact of mastectomy with that of lumpectomy.4'6 None of those studies in which psychiatric morbidity was adequately assessed showed any advantage to women who underwent breast conservation surgery. The small numbers of patients studied, however, meant that differences in psychiatric morbidity between treatment groups would have had to be very large to attain significance. In general, most studies reported a reduction in problems relating to body image in women who did not lose a breast, although one of the studies, which was reported by us, suggested that this advantage was offset by greater fears of cancer and of its possible recurrence."' Our findings in this randomised trial, in which women were interviewed retrospectively, were criticised because the number of patients was small (101) and the assessments were retrospective. In addition, several authors suggested that randomised allocation to treatment after informed consent produced bias or was responsible for the psychosexual problems found. ' short term follow up in small samples of women and incomplete reporting of data.' 12 14 17 We conducted a prospective study of the psychological adjustment in a large sample of women by using validated assessment measures with a lengthier follow up than had been evident in earlier reports. Furthermore, we thought that the psychological impact of women's knowledge or ignorance that they were in a clinical trial had received wide publicity but little systematic study'9121; thus we conducted this pragmatic study also to ducted by a trained interviewer about two weeks, three months, and 12 months postoperatively. Interviews took place in patients' homes to permit a more intimate discussion than is usually possible in busy hospitals. At the first home interview relevant social information (such as marital and occupational state and social support available) was collected, together with details as to how the breast lump was discovered, the woman's initial reactions to this discovery, and her recall of the way in which the diagnosis and treatment decisions were discussed. We asked women whether or not they felt that they had been offered a choice of treatment, how adequate the information given had been, and whether their primary fear on hearing the diagnosis was about possible breast loss or the fact of having cancer, or both. Interviews were tape recorded to permit tests of rate-rerate and interrater reliability.
At registration the surgeons indicated how they had decided on treatment (that is, on the basis of the patient's preference, the surgeon's preference, or for technical reasons). The Anxiety by surgeon group-At each assessment anxiety ratings were high (table V) . However, univariate analysis provided no firm suggestion of the effect of surgeon type (p=0-1). With multivariate analysis a significant effect of surgeon type was found (p=0-01); the odds ratios for women treated by surgeons who favoured mastectomy, lumpectomy, and choice were 100, 0 57, and 0-22 respectively. These ratios indicate BMJ VOLUME 301 a decreasing incidence of anxiety across the three groups.
Depression by treatment group-Between 15% and 29% of women irrespective of treatment were found to be depressed at each assessment ( tSeventeen women did not express either concern.
was compared with that in women who were treated by all three types of surgeons and who did not have a real choice there are no significant advantages to the women with a choice (table VIII) , although those women who chose mastectomy seemed less anxious and depressed than those who underwent this treatment but had no choice. Follow up data for two and three years after treatment are still being collected, so it is too early to make any firm statements about the putative benefits of offering patients a choice of treatment.
Factors affecting choice-At interview women who chose mastectomy had firmer convictions about the benefits of mastectomy in terms of removing all of the cancer. Most of the women gave fear of cancer as their worst thought rather than fear of breast loss, irrespective of the eventual surgical treatment they received (table IX) . Only 32 of 269 (12%) women, 18 of whom underwent mastectomy and 14 of whom underwent lumpectomy, thought that the fear of losing a breast was worse than that of having cancer.
Assumptions that elderly women do not mind losing a breast are not supported by our data: 13 of 21 women over 60 who were able to choose their treatment opted for lumpectomy (table III) .
COMPARISON WITH BREAST CONSERVATION STUDY
Anxiety-Almost 12 months after operation 14 of the 53 (26%) women who underwent mastectomy after randomisation in the breast conservation study experienced an anxiety state compared with 39 of 140 (28%) in the current study. Fifteen of 48 (31%) women after lumpectomy in the randomised clinical trial were anxious compared with 29 of 108 (27%) in the current study. Thus the incidence of anxiety was almost identical in both studies, irrespective of surgical treatment.
Depression -For women who underwent mastectomy the incidence ofdepressive illness was identical in both studies. Eleven out of 53 (21%) women who underwent mastectomy after randomisation were depressed compared with 30 out of 140 (21%) in the current study. Thirteen of 48 (27%) women who underwent lumpectomy after randomisation were depressed compared with 20 out of 108 (19%) in the current study. None of these differences were significant. Sexual dysfunction-A single self report item on the Rotterdam symptom checklist assessed loss of sexual interest. Eighteen of the 48 (38%) women with sexual partners who underwent mastectomy and 15 out of 39 (38%) who underwent lumpectomy in the breast conservation trial reported a loss of sexual interest compared with 33 of 120 (28%) and 30 of 100 (30%) women in the current study. There was no significant difference between the two treatment groups or between the two studies, with well over a quarter of all women reporting sexual dysfunction.
Satisfaction with information given-The protocol for the breast conservation trial required that participating surgeons discussed treatment options with patients to determine whether they had any strong preference for one particular surgical procedure before randomisation. In addition, most ethical committees of the centres participating in the study demanded fully informed consent. Despite this emphasis on the giving of information 52 of 100 (52%) of the women thought that they had received inadequate information. Furthermore, those women who thought that they had been poorly informed were twice as likely to be depressed or anxious, or both, at 12 months compared with those who thought that they had been adequately informed. In the current study 54 of 152 (36%) women who underwent mastectomy and 26 of 115 (23%) women who underwent lumpectomy thought that the information given at the hospital was inadequate (data are missing for two patients).
An interesting finding, which again supports data from the breast conservation study, concerns the difference in the incidence of anxiety or depression, or both, at 12 months. There are complete data for 246 women (data are missing because of death or unavailability of patients). Of the 176 women who thought that they had been well informed, 46 (26%) were assessed as anxious or depressed; but of those women who thought that they had been poorly informed 32 out of 70 (46%) were anxious or depressed, or both (p=0 005 by X2 test). As the breast conservation study was retrospective it was not possible to determine the direction of causality: Were those patients in whom anxiety was found anxious because they had been poorly informed or was their perception of the information given to them affected by the fact that they were anxious to start with?
In the current prospective study women were given preoperatively the Spielberger state/trait anxiety inventory, a self report questionnaire used to identify those people in whom anxiety is a characteristic trait.24 The mean (SD) score for those who thought they had been inadequately informed was 39-9 (11-45), and for those who thought that they had been adequately informed it was 34-86 (9 95 Our results suggest that the way in which the surgeon conducts the consultation during which the bad news that cancer is present is given may have important consequences for long term adjustment. Women in whom anxiety is a characteristic trait are more likely to perceive the information as inadequate and be clinically anxious or depressed, or both, at 12 months. If these anxiety prone women can be identified at an early stage by the use of screening systems such as the Spielberger state/trait anxiety inventory before seeing the surgeon then intervention could be possible. These women may well need a close companion to accompany them during the consultation. 33 They also might benefit from taking home an audio tape recording of the interview.34 Finally, they may require more help in discussing the information with a properly trained oncology counsellor or breast nurse specialist.33 35 Ethical dilemmas abound in the field of breast cancer research. Some of the most vociferous proponents of the controversies jeopardise their arguments by ignoring the more fundamental ethical dilemma of providing care in the absence of any research evidence. Consumer choice without scientific knowledge of likely outcomes is meaningless. Opinions vary from "concern for the interests of the subject must always prevail over the interests of science and society"36 to beliefs that it is unethical not to conduct a controlled trial when clinicians recognise their uncertainty. 37 The worries that fully informing women of this uncertainty at a time when they are already experiencing emotional distress about having a life threatening disease are real. Indeed, problems with informed consent have been one ofthe most commonly expressed reasons for not entering eligible women into trials of breast cancer surgery.2138 There is no evidence from our work, however, to suggest that participation in a randomised clinical trial of surgery for BMJ VOLUME 301 22 SEPTEMBER 1990 early breast cancer in itself produces psychiatric morbidity.
